Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease

Journal of Hepatology

Volumn 55, Issue 1, 2011, Pages 38-44

  Trépo, Eric ^a,b   Potthoff, Andrej ^f   Pradat, Pierre ^c,d,e,j   Bakshi, Rakesh ^f   Young, Bradford ^g   Lagier, Robert ^g   Moreno, Christophe ^a,b   Verset, Laurine ^b   Cross, Richard ^h   Degré, Delphine ^a,b   Lemmers, Arnaud ^a,b   Gustot, Thierry ^a,b   Berthillon, Pascale ^d,e   Rosenberg, William ⁱ   Trépo, Christian ^c,d,e   Sninsky, John ^g   Adler, Michael ^b   Wedemeyer, Heiner ^f  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c HÔTEL DIEU   (France)

^d INSERM   (France)

^e UNIVERSITÉ LYON 1   (France)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g CELERA   (United States)

^h SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j CROIX ROUSSE HOSPITAL   (France)

more..

Author keywords

Cirrhosis risk score (CRS); Fibrosis progression; Hepatitis C; Minimal liver disease

Indexed keywords

OLIGONUCLEOTIDE;

ADULT; ARTICLE; BELGIUM; CALCULATION; CIRRHOSIS RISK SCORE; COHORT ANALYSIS; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; ENHANCED LIVER FIBROSIS TEST; FEMALE; FOLLOW UP; GENOTYPE; GERMANY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MINIMAL LIVER DISEASE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SIGNAL TRANSDUCTION;

COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC VARIATION; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79958822599     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.10.018     Document Type: Article

References (34)

1. World Health Organization. Initiative for Vaccine Research. Hepatitis C virus. Available from: http://www.who.int/vaccine-research/diseases/viral- cancers/en/index2.html (visited 23.02.2010).
2. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection The Lancet infectious diseases 5 2005 558 567 (Pubitemid 41196755)
3. L.B. Seeff The history of the "natural history" of hepatitis C (1968-2009) Liver Int 29 2009 89 99
4. P. Marcellin, T. Asselah, and N. Boyer Fibrosis and disease progression in hepatitis C Hepatology 36 2002 S47 56
5. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832 (Pubitemid 27129209)
6. G.L. Davis, M.J. Alter, H. El-Serag, T. Poynard, and L.W. Jennings Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521
7. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
8. A. Mallat, C. Hezode, and S. Lotersztajn Environmental factors as disease accelerators during chronic hepatitis C J Hepatol 48 2008 657 665
9. S.B. Missiha, M. Ostrowski, and E.J. Heathcote Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors Gastroenterology 134 2008 1699 1714 (Pubitemid 351615412)
10. L.B. Seeff, F.B. Hollinger, H.J. Alter, E.C. Wright, C.M. Cain, and Z.J. Buskell Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study Hepatology 33 2001 455 463 (Pubitemid 32119036)
11. M. Wright, R. Goldin, A. Fabre, J. Lloyd, H. Thomas, and C. Trepo Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study Gut 52 2003 574 579 (Pubitemid 36363414)
12. P. Pradat, H.L. Tillmann, S. Sauleda, J.H. Braconier, G. Saracco, and M. Thursz Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications J Viral Hepatol 14 2007 556 563 (Pubitemid 47075428)
13. M. Thursz, R. Yallop, R. Goldin, C. Trepo, and H.C. Thomas Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research Lancet 354 1999 2119 2124 (Pubitemid 30008896)
14. T. Asselah, I. Bieche, V. Paradis, P. Bedossa, M. Vidaud, and P. Marcellin Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C Semin Liver Dis 27 2007 13 27
15. R. Bataller, K.E. North, and D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503 (Pubitemid 36258768)
16. H. Huang, M.L. Shiffman, S. Friedman, R. Venkatesh, N. Bzowej, and O.T. Abar A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 46 2007 297 306 (Pubitemid 47344763)
17. S. Deuffic-Burban, P. Deltenre, A. Louvet, V. Canva, S. Dharancy, and A. Hollebecque Impact of viral eradication on mortality related to hepatitis C: a modeling approach in France J Hepatol 49 2008 175 183
18. M.G. Ghany, D.B. Strader, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
19. P. Bedossa, D. Dargere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457 (Pubitemid 37466971)
20. M.C. Rousselet, S. Michalak, F. Dupre, A. Croue, P. Bedossa, and J.P. Saint-Andre Sources of variability in histological scoring of chronic viral hepatitis Hepatology 41 2005 257 264 (Pubitemid 40165369)
21. W.M. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, and D. Schuppan Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713 (Pubitemid 39575849)
22. J. Parkes, I.N. Guha, P. Roderick, S. Harris, R. Cross, and M.M. Manos Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C J Viral Hepat 1 2010 1 2
23. J. Parkes, P. Roderick, S. Harris, C. Day, D. Mutimer, and J. Collier Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease Gut 59 2010 1245 1251
24. J. Westin, L.M. Lagging, R. Wejstal, G. Norkrans, and A.P. Dhillon Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection Liver 19 1999 183 187 (Pubitemid 29261583)
25. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
26. E. Trepo, F. Bailly, C. Moreno, A. Lemmers, C. Trepo, and M. Adler Hepatitis C and menopause: interplay of age, gender, HCV replication and activity in progression and consequence for therapy Hepatology 50 2009 1059A 1060A
27. M. Marcolongo, B. Young, F. Dal Pero, G. Fattovich, L. Peraro, and M. Guido A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C Hepatology 50 2009 1038 1044
28. S. Boccato, R. Pistis, F. Noventa, M. Guido, L. Benvegnu, and A. Alberti Fibrosis progression in initially mild chronic hepatitis C J Viral Hepat 13 2006 297 302
29. M.G. Ghany, D.E. Kleiner, H. Alter, E. Doo, F. Khokar, and K. Promrat Progression of fibrosis in chronic hepatitis C Gastroenterology 124 2003 97 104 (Pubitemid 36055343)
30. N.H. Afdhal, A.S. Lok, and A.M. Di Bisceglie Clinical decisions. Management of incidental hepatitis C virus infection N Engl J Med 360 2009 1902 1906
31. S. Deuffic-Burban, G. Babany, I. Lonjon-Domanec, P. Deltenre, V. Canva-Delcambre, and S. Dharancy Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France Hepatology 50 2009 1351 1359
32. L. Castera, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350 (Pubitemid 40439195)
33. T. Poynard, R. Morra, P. Halfon, L. Castera, V. Ratziu, and F. Imbert-Bismut Meta-analyses of FibroTest diagnostic value in chronic liver disease BMC gastroenterology 7 2007 40
34. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401